231 related articles for article (PubMed ID: 18158319)
1. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses.
Lazarczyk M; Pons C; Mendoza JA; Cassonnet P; Jacob Y; Favre M
J Exp Med; 2008 Jan; 205(1):35-42. PubMed ID: 18158319
[TBL] [Abstract][Full Text] [Related]
2. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
Orth G
Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
[TBL] [Abstract][Full Text] [Related]
3. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
4. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.
Lazarczyk M; Cassonnet P; Pons C; Jacob Y; Favre M
Microbiol Mol Biol Rev; 2009 Jun; 73(2):348-70. PubMed ID: 19487731
[TBL] [Abstract][Full Text] [Related]
5. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
Orth G
Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in
Torres AD; King RE; Uberoi A; Buehler D; Yoshida S; Ward-Shaw E; Lambert PF
J Virol; 2024 Jun; ():e0017424. PubMed ID: 38869286
[TBL] [Abstract][Full Text] [Related]
7. The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.
de Jong SJ; Créquer A; Matos I; Hum D; Gunasekharan V; Lorenzo L; Jabot-Hanin F; Imahorn E; Arias AA; Vahidnezhad H; Youssefian L; Markle JG; Patin E; D'Amico A; Wang CQF; Full F; Ensser A; Leisner TM; Parise LV; Bouaziz M; Maya NP; Cadena XR; Saka B; Saeidian AH; Aghazadeh N; Zeinali S; Itin P; Krueger JG; Laimins L; Abel L; Fuchs E; Uitto J; Franco JL; Burger B; Orth G; Jouanguy E; Casanova JL
J Exp Med; 2018 Sep; 215(9):2289-2310. PubMed ID: 30068544
[TBL] [Abstract][Full Text] [Related]
8. Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology.
O'Blenes C; Pasternak S; Issekutz A; Gillis J; Chowdhury D; Finlayson L
Pediatr Dermatol; 2015; 32(1):118-21. PubMed ID: 23534907
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
10. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
11. Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn.
Carlson JA; Cribier B; Nuovo G; Rohwedder A
J Am Acad Dermatol; 2008 Aug; 59(2):279-94. PubMed ID: 18638629
[TBL] [Abstract][Full Text] [Related]
12. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
[TBL] [Abstract][Full Text] [Related]
14. EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation.
Lazarczyk M; Dalard C; Hayder M; Dupre L; Pignolet B; Majewski S; Vuillier F; Favre M; Liblau RS
PLoS One; 2012; 7(6):e39995. PubMed ID: 22761942
[TBL] [Abstract][Full Text] [Related]
15. High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis.
Mahé E; Bodemer C; Descamps V; Mahé I; Crickx B; De Prost Y; Favre M
Br J Dermatol; 2003 Oct; 149(4):819-25. PubMed ID: 14616375
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 5.2 acts as a transcription repressor of Epidermodysplasia verruciformis-associated human papillomaviruses.
Akgül B; Cürten M; Haigis H; Rogosz I; Pfister H
Arch Virol; 2006 Dec; 151(12):2461-73. PubMed ID: 16773233
[TBL] [Abstract][Full Text] [Related]
17. HPV: CIB1 is for EVER and EVER.
Notarangelo LD
J Exp Med; 2018 Sep; 215(9):2229-2231. PubMed ID: 30068545
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of epidermodysplasia verruciformis human papillomaviruses in the immunopathogenesis of psoriasis: a proposed hypothesis.
Majewski S; Jablonska S
Exp Dermatol; 2003 Dec; 12(6):721-8. PubMed ID: 14714550
[TBL] [Abstract][Full Text] [Related]
19. Homozygosity for the c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz.
Arnold AW; Burger B; Kump E; Rufle A; Tyring SK; Kempf W; Häusermann P; Itin PH
Dermatology; 2011 Feb; 222(1):81-6. PubMed ID: 21196704
[TBL] [Abstract][Full Text] [Related]
20. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
